Clinical Innovation CHLA is actively investing in pediatric oncology decision-support tools, exemplified by the launch of a clinical decision tool to optimize thiopurine therapy for leukemia. This signals a strong opportunity for health IT vendors, analytics platforms, and clinical decision support integrations.

Research Funding As a top 10 finalist for pediatric research funding with NIH recognition and a recent $17.3M autism research grant, CHLA demonstrates substantial potential appetite for grant-aligned partnerships, data collaboration, and protocol-driven research platforms.

Leadership Strength Appointment of a Radiologist-in-Chief and other prominent researchers indicates a strategic focus on imaging, radiology workflows, and advanced diagnostics—areas ripe for AI imaging tools, PACS integrations, and radiology informatics solutions.

Caregiver Support Collaborations with caregiver-focused initiatives and Revitalize Program partners highlight CHLA’s emphasis on workforce well-being and patient-family experience, suggesting opportunities for human capital tech, wellness platforms, and caregiver engagement solutions.

Digital & Cloud With a tech stack including Microsoft Azure and infrastructure tooling, CHLA is positioned for cloud-based health IT modernization, data interoperability projects, and scalable security/compliance solutions targeting pediatric enterprise needs.